Search Results - F Peyvandi

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Evolution of Haemophilia Care in Europe: 10 years of the principles of care by D. Noone, B. O’Mahony, F. Peyvandi, M. Makris, A. Bok

    Published in Orphanet Journal of Rare Diseases (2020-07-01)
    Get full text
    Article


  2. 2

    EFFICACY AND SAFETY OF VALOCTOCOGENE ROXAPARVOVEC 4 YEARS AFTER GENE TRANSFER IN GENER8-1 by MC Ozelo, AD Leavitt, J Mahlangu, G Kenet, SW Pipe, S Chou, R Klamroth, F Peyvandi, T Robinson, GT Group

    Published in Hematology, Transfusion and Cell Therapy (2024-10-01)
    Get full text
    Article


  3. 3

    A SIMULATION STUDY TO PROVIDE GUIDANCE FOR INDIVIDUALS TRANSITIONING FROM EMICIZUMAB TO VALOCTOCOGENE ROXAPARVOVEC by W Kuwabara, D Osmond, J Henshaw, S Agarwal, V Newman, C Hermans, W Miesbach, S Pipe, RS Jr, F Peyvandi

    Published in Hematology, Transfusion and Cell Therapy (2023-10-01)
    Get full text
    Article


  4. 4

    BLEEDING, FVIII ACTIVITY, AND SAFETY 3 YEARS AFTER GENE TRANSFER WITH VALOCTOCOGENE ROXAPARVOVEC: RESULTS FROM GENER8-1 by MC Ozelo, J Mahlangu, B Madan, J Mason, F Peyvandi, AV Drygalski, G Yamaguti-Hayakawa, TM Robinson, SW Pipe, TT Gener-Eigh

    Published in Hematology, Transfusion and Cell Therapy (2023-10-01)
    Get full text
    Article


  5. 5

    OUTCOMES OF PATIENTS WITH WORSENING ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) DESPITE DAILY THERAPEUTIC PLASMA EXCHANGE IN THE PHASE 3 HERCULES TRIAL by M. Scully, J.L. Rubia, F. Peyvandi, S. Cataland, P. Coppo, J.A.K. Hovinga, P. Knoebl, K. Pavenski, F. Callewaert, J.M.M. Edou, R.P. Sousa

    Published in Hematology, Transfusion and Cell Therapy (2020-11-01)
    Get full text
    Article


  6. 6

    S294: LONG-TERM SAFETY AND EFFICACY OF CAPLACIZUMAB FOR ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (ATTP): THE POST-HERCULES STUDY by M. Scully, J. de la Rubia, K. Pavenski, A. Metjian, P. Knöbl, F. Peyvandi, S. Cataland, P. Coppo, J. A. Kremer Hovinga, R. De Passos Sousa, F. Callewaert, S. Gunawardena, J. Lin

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  7. 7

    Reduced circulating FABP2 in patients with moderate to severe COVID-19 may indicate enterocyte functional change rather than cell death by G. Assante, A. Tourna, R. Carpani, F. Ferrari, D. Prati, F. Peyvandi, F. Blasi, A. Bandera, A. Le Guennec, S. Chokshi, V. C. Patel, I. J. Cox, L. Valenti, N. A. Youngson

    Published in Scientific Reports (2022-11-01)
    Get full text
    Article


  8. 8

    Thrombotic thrombocytopenic purpura and defective apoptosis due to CASP8/10 mutations: the role of mycophenolate mofetil by F. Fioredda, E. Cappelli, A. Mariani, A. Beccaria, E. Palmisani, A. Grossi, I. Ceccherini, R. Venè, C. Micalizzi, M. Calvillo, F. Pierri, I. Mancini, F. Peyvandi, F. Corsolini, C. Dufour, M. Miano

    Published in Blood Advances (2019-11-01)
    Get full text
    Article


Search Tools: